Literature DB >> 7972820

Closure of the cerebellar vermis: evaluation with second trimester US.

B Bromley1, A S Nadel, S Pauker, J A Estroff, B R Benacerraf.   

Abstract

PURPOSE: To evaluate with sonography the normal development of the fetal cerebellum in the second trimester.
MATERIALS AND METHODS: The study included all patients undergoing second trimester genetic amniocentesis who had structurally normal fetuses, in whom the posterior fossa was adequately seen and in whom the karyotype was later determined to be normal. Views of the cerebellum were obtained prospectively, and the inferior vermis was determined to be open or closed at the time of the initial scan. Follow-up was obtained by means of subsequent scans and review of the pediatric record.
RESULTS: Of 897 fetuses that met the inclusion criteria, 147 had an open vermis at initial scanning. At 14 weeks gestation, 56% of fetuses had an open vermis, decreasing to 23% at 15 weeks and 6% at 17 weeks. In utero follow-up sonograms were obtained in 79% of fetuses with an initially open vermis and demonstrated closure in all but one fetus. The remaining 21%, without sonographic follow-up, were normal as newborns.
CONCLUSION: The prenatal diagnosis of Dandy-Walker variant should not be made before 18 weeks gestation because the development of the cerebellar vermis may be incomplete at that time.

Entities:  

Mesh:

Year:  1994        PMID: 7972820     DOI: 10.1148/radiology.193.3.7972820

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  13 in total

Review 1.  Practical approach to prenatal posterior fossa abnormalities using MRI.

Authors:  Laurent Guibaud
Journal:  Pediatr Radiol       Date:  2004-08-04

Review 2.  Clinical and molecular features of Joubert syndrome and related disorders.

Authors:  Melissa A Parisi
Journal:  Am J Med Genet C Semin Med Genet       Date:  2009-11-15       Impact factor: 3.908

3.  Diagnosis of Joubert syndrome via ultrasonography.

Authors:  Baris Buke; Emre Canverenler; Göksun İpek; Semiha Canverenler; Hatice Akkaya
Journal:  J Med Ultrason (2001)       Date:  2016-10-26       Impact factor: 1.314

Review 4.  MRI of the fetal posterior fossa.

Authors:  Catherine Adamsbaum; Marie Laure Moutard; Christine André; Valérie Merzoug; Solène Ferey; Marie Pierre Quéré; Fanny Lewin; Catherine Fallet-Bianco
Journal:  Pediatr Radiol       Date:  2004-11-23

Review 5.  Pre- and Postnatal Neuroimaging of Congenital Cerebellar Abnormalities.

Authors:  Andrea Poretti; Eugen Boltshauser; Thierry A G M Huisman
Journal:  Cerebellum       Date:  2016-02       Impact factor: 3.847

6.  Diagnosis of inferior vermian hypoplasia by fetal magnetic resonance imaging: potential pitfalls and neurodevelopmental outcome.

Authors:  Catherine Limperopoulos; Richard L Robertson; Judy A Estroff; Carol Barnewolt; Deborah Levine; Haim Bassan; Adré J du Plessis
Journal:  Am J Obstet Gynecol       Date:  2006-04       Impact factor: 8.661

Review 7.  A different approach to cysts of the posterior fossa.

Authors:  Marvin D Nelson; Karima Maher; Floyd H Gilles
Journal:  Pediatr Radiol       Date:  2004-07-30

8.  Long-term developmental outcome of children with a fetal diagnosis of isolated inferior vermian hypoplasia.

Authors:  Tomo Tarui; Catherine Limperopoulos; Nancy R Sullivan; Richard L Robertson; Adre J du Plessis
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2013-08-20       Impact factor: 5.747

9.  How accurately does current fetal imaging identify posterior fossa anomalies?

Authors:  Catherine Limperopoulos; Richard L Robertson; Omar S Khwaja; Caroline D Robson; Judy A Estroff; Carole Barnewolt; Deborah Levine; Donna Morash; Luanne Nemes; Linda Zaccagnini; Adré J du Plessis
Journal:  AJR Am J Roentgenol       Date:  2008-06       Impact factor: 3.959

10.  Joubert syndrome and related disorders, prenatal diagnosis with ultrasound and magnetic resonance imaging.

Authors:  Can Tekin Iskender; Ebru Tarım; Ozlem Alkan
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.